GSK share price slips into the weekend as investors brace for Feb. 4 results
GSK shares fell 1.7% to 1,816.5 pence in London Friday, with trading volume above recent averages. Senior executives disclosed routine share purchases via dividend reinvestment. Investors now await GSK’s fourth-quarter results on Feb. 4 and the upcoming dividend timetable. Debate continues over U.S. fast-track drug approvals, with GSK linked to the FDA’s voucher program.